Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

AbbVie Inc. ABBV

Healthcare  —  Drug Manufacturers General
264.34 (0.78) (0.29%) as of 25 Sep
Market cap
$467.4B
P/E
74.7×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

AbbVie Inc. (ABBV) P/E ratio

As of 25 September 2026, AbbVie Inc. (ABBV) trades at a P/E ratio of 74.7×. Over the past ten years it has ranged from 12.2× (March 2020) to 185× (October 2025); the current reading is higher than 88% of that period. That is above the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 96.8× 30.76%
FY2024 74.0× 26.48%
FY2023 58.5× 138.31%
FY2022 24.6× 17.02%
FY2021 21.0× (43.97%)
FY2020 37.5× 123.42%
FY2019 16.8× (34.88%)
FY2018 25.8× (13.91%)
FY2017 29.9× 73.98%
FY2016 17.2× (9.45%)

Quarterly

Period P/E ratio Change
Jun 2026 71.1× (33.65%)
Mar 2026 107× 10.66%
Dec 2025 96.8× (44.80%)
Sep 2025 175× 98.45%
42 more quarters

Against its own ten years

Low 12.2× High 185×
Ten-year median 27.6×
Current reading's percentile 88

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
JNJ Johnson & Johnson compare 31.4×
PFE Pfizer Inc. compare 37.7×
LLY Eli Lilly and Company compare 39.7×
ABBV AbbVie Inc. 74.7×
MRK Merck & Co., Inc. compare 119×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ABBV